Clinical Study in Healthy Men to Investigate the Uptake of Buprenorphine and Its Elimination From the Body After Dermal Application as Patches for 96 Hours and for 72 Hours
Conditions: Pain; Pharmacokinetics Intervention: Drug: Transtec 35 µg/hour transdermal patch Sponsor: Grünenthal GmbH Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials